CEPH (Cephalon)
All Pro Portfolios with CEPH

People owning CEPH also tend to own:: ABTAGNBMYBRLENDPFRXHSP

All Do-It-Yourself Portfolios with CEPH
  • News For Selected Stock
  • Related stories on theStreet.com
  • videos related to etf's
  • No videos found
  •  
  • 08/11/09

Why I Love This Stock

By:barrons3

Date:07 08 09

Also, Cephelon (CEPH) may be another stock to watch. David Windley recommends getting in at current levels.

Not yet rated
Rate now:

By:barrons3

Date:03 21 09

Outperform -- Price 63.19 on March 17
by Baird Securities

Target: 80. CEPH's Nuvigil had statistically significant efficacy as an adjunctive therapy to mood stabilizers in a Phase 2 bipolar I depression trial...Top-line safety/tolerability was comparable to placebo...We apply a price/earnings ratio of 14 (group average recently in range of 15 to 20 times, historically 20 to 30 times) to our 2010 estimated earnings per share....The discounted multiples represent those recently awarded by the market. Market cap: $4.9 billion.

Not yet rated
Rate now:

By:sarah z

Date:02 23 09

Maybe the difficulty in reconciling Helene Meisler's view on the NASDAQ to Doug Kass's view on the NASDAQ (link) is biotech!
Helene doesn't like the Nazz, thinks it is about to roll over. Doug's on board -- he likes the action and is long.
Perhaps the difference in views is that I am thinking of this index as tech when I should be thinking of it as biotech -- namely Cephalon (CEPH), Genzyme (GENZ), Celgene (CELG), Gilead (GILD), Biogen (BIB), Amgen (AMGN) and Sepracor (SEPR) plus a bunch of other healthcare players.
The Nazz has the benefits of almost no banks, lots of techs with big cash positions and these biotech wonders that have acted fabulously since the year began.
Sometimes an index isn't what it seems. The biotechs, subliminally, may be the reason why the Nasdaq rallied even on this awful day. I predict continued outperformance by biotech in this world of zero interest rates. So, tie goes to Dougie!
Random musings: Good discussion with Jeremy Siegal and Jack Bogle on Street Signs today, with Jeremy pointing out that dividend stocks have held up but Jack noticing growth stocks are up more. In reality, both have been losers... Tim Geithner and the ProShares UltraShort Financial (SKF) destroyed the banks this week. I will have more SKF data on Monday that shows how much the shorts had to do with this move down.

Not yet rated
Rate now:

By:Trading Nymph

Date:12 30 08

4

Not yet rated
Rate now:

By:KBP

Date:11 04 08

Technicals and Fundamentals

Not yet rated
Rate now:

By:barrons2

Date:07 24 08

Don't forget that the whole group is running, including Biogen (BIIB), as the B section of the Journal shows, and Cephalon (CEPH), which seems like nothing but net lately.

Not yet rated
Rate now:

By:Pro

Date:11 30 -1

Cephalon (CEPH) was upgraded from Neutral to Buy, Merrill Lynch said. Stock is trading at a low valuation, already pricing in poor prescription trends. $73 price target.

Not yet rated
Rate now:

By:Pro

Date:11 30 -1

Cephalon (CEPH) was upgraded from Market-weight to Overweight, Thomas Weisel said. $77 price target. Company has endured several negative milestones and its base business remains intact. Pipeline also has big potential.

Not yet rated
Rate now:

By:Pro

Date:11 30 -1

Cephalon (CEPH) was downgraded to Underweight, Morgan Stanley said. $54 price target. Company faces more significant challenges down the road. Near-term prescription trends are also weakening.

Not yet rated
Rate now:

By:Pro

Date:11 30 -1

FBR said it is upgrading Cephalon (CEPH) to an Outperform rating and raising its target price to $97. Market opportunity for Treanda is not fully appreciated.

Not yet rated
Rate now:

Why I Hate This Stock

By:lekjr

Date:12 07 07

unable to time properly

Not yet rated
Rate now:

By:JOCKOBRATZI

Date:09 13 07

WARNING

Not yet rated
Rate now:
Add Your Comments  
Stock CEPH
Allowed HTML tags: <a><b><i><img>
  Login to post your comments
This Week's 'Barron's' Roundup

By Roberto Pedone Posted on Nov. 9, 2009 Financial-Services Bull: Barron’s talks with Anton Schutz, portfolio manager at the Burnham Financial Industries Fund (BURFX)...

11.09.09 | 11:01 AM
Rocket Stocks for the Week

By Jonas Elmerraji Posted on Nov. 9, 2009 Last week brought investors a welcome return to gains as the S&P 500 pushed up 3.2% over the course of the last five trading d...

11.09.09 | 08:04 AM
Jim Cramer's Portfolios of the Week

By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...

11.06.09 | 15:52 PM
'Fast Money' Portfolios of the Week

By Roberto Pedone Posted on Nov. 5, 2009 The traders on CNBC’s “Fast Money” told their viewers what they must know after Warren Buffett announced on Tuesday his l...

11.05.09 | 12:05 PM
more articles
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
Full Disclosure
11.09.08 | 12:30 PM From author alchemist
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
more forums
today 's lists
Stocks With Unusual Option Activity

Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more

Analyst Downgrades

Analyst Downgrades for Nov. 2, 2009. Read more here. more

Dogs of the Dow

Here are the 10 stocks in the Dow Jones Industrial Average stocks with the highest yields as of the market close on June 2, 2009. more